Quantamental Investing to beat Benchmarks

A. Stotz Investment Research

We pick stocks. We construct portfolios. All our effort is focused on how to better pick stocks and construct portfolios. We serve fund management companies, family offices, and high net worth individuals.

Thoughts on Amazon –What Does Its Valuation Tells Us?

Netflix & Amazon Expand in Korea – Not a Coincidence

Okja: The Fight Between Netflix Vs. CJ CGV

CEO, A. Stotz Investment Research

Dr. Andrew Stotz, CFA

Equity Bottom-Up

<ul><li>Cheap on a gross profit basis, low price volatility versus the market and good growth in core profit relative to its sector</li><li>Its JV with Malee (MALEE TB) to produce clinically proven natural food &amp; beverages shows acumen to serve the aging population in Thailand</li><li>MEGA’s performance for 2H16 should continue to be strong with the approaching peak season and the company’s effective cost controls; 2Q16 profits were up 32% YoY</li><li>The stock is attractive at 16CE* 4.5% ROE/PB compared to Thai Health Care at 2.6% and MEGA has a solid net-cash position</li><li>Risks: Unable to control marketing costs</li></ul><p><em>* Consensus Estimates</em></p>

Cheap on a gross profit basis, low price volatility versus the market and good growth in core profit relative to its sectorIts JV with Malee (MALEE TB) to produce clinically proven natural food &amp; beverages shows acumen to serve the aging population in ThailandMEGA’s performance for 2H16 should continue to be strong with the approaching peak season and the company’s effective cost controls; 2Q16 profits were up 32% YoYThe stock is attractive at 16CE* 4.5% ROE/PB compared to Thai Health Care at 2.6% and MEGA has a solid net-cash positionRisks: Unable to control marketing costs* Consensus Estimates

Mega Lifesciences

MEGA: Catering to an Aging Population